Results for 'pediatric cancer; phase 1 trials; drug development; targeted therapy; disparity'
Browse oncology articles matching pediatric cancer; phase 1 trials; drug development; targeted therapy; disparity — expert analysis, clinical perspectives, and industry updates from across drug development and care delivery. Use the tabs above for podcasts, press releases, partners, and people for the same search.
Dylan V. Neel, MPhil, David S. Shulman, MD, and Steven G. DuBois, MD
Timing of first-in-child trials of FDA-approved oncology drugs
pediatric cancer; phase 1 trials; drug development; targeted therapy; disparity
Aim: To define the lag time between initial human studies and first-in-child clinical trials of oncology agents. Methods: Systematic analysis of time from first-in-human trials to first-in-child trials for agents approved by the FDA from 1997 to 2017. Dat…
Mar 18th • 10 mins read